Samuel Strober ((1940-05-08)May 8, 1940-February 11, 2022(2022-02-11) (aged 81)[1]) was a biomedical researcher and inventor best known for his work on the elimination of the need for lifelong immune suppressive drugs in organ transplant patients.
[2] Strober was born in Brooklyn, New York, on May 8, 1940, and received his bachelor's degree from Columbia College in 1961,[1][3] and his MD from the Harvard Medical School[4] in 1966.
He also studied at Massachusetts General[5] and Stanford University Hospitals[6] and the Sir William Dunn School of Pathology[7] at Oxford University.
He was chief of the Division of Immunology and Rheumatology[8][9] at the Stanford University School of Medicine (1979–1997); a co-founder of a biotechnology company, Dendreon, that developed the first FDA approved cancer vaccination; President of the Clinical Immunology Society (1996);[10] and chairman of the Board of Directors of the La Jolla Institute for Allergy and Immunology.
[14] His first wife is feminist economist Myra Strober, who decided to keep the Strober last name after she remarried.